Cargando…
Bleeding in cardiac patients prescribed antithrombotic drugs: electronic health record phenotyping algorithms, incidence, trends and prognosis
BACKGROUND: Clinical guidelines and public health authorities lack recommendations on scalable approaches to defining and monitoring the occurrence and severity of bleeding in populations prescribed antithrombotic therapy. METHODS: We examined linked primary care, hospital admission and death regist...
Autores principales: | Pasea, Laura, Chung, Sheng-Chia, Pujades-Rodriguez, Mar, Shah, Anoop D., Alvarez-Madrazo, Samantha, Allan, Victoria, Teo, James T., Bean, Daniel, Sofat, Reecha, Dobson, Richard, Banerjee, Amitava, Patel, Riyaz S., Timmis, Adam, Denaxas, Spiros, Hemingway, Harry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864929/ https://www.ncbi.nlm.nih.gov/pubmed/31744503 http://dx.doi.org/10.1186/s12916-019-1438-y |
Ejemplares similares
-
Personalising the decision for prolonged dual antiplatelet therapy: development, validation and potential impact of prognostic models for cardiovascular events and bleeding in myocardial infarction survivors
por: Pasea, Laura, et al.
Publicado: (2017) -
Models for mortality require tailoring in the context of the COVID-19 pandemic – Authors' reply
por: Banerjee, Amitava, et al.
Publicado: (2020) -
Time spent at blood pressure target and the risk of death and cardiovascular diseases
por: Chung, Sheng-Chia, et al.
Publicado: (2018) -
Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care
por: Allan, Victoria, et al.
Publicado: (2017) -
Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort
por: Handy, Alex, et al.
Publicado: (2022)